87 Cambridge Park Drive Cambridge, Massachusetts 02140 (Address of Principal Executive Offices) (Zip Code)

there is no need to quench azide in situ with nitrite in the reaction mix with the product – they could have done it with mother liquors after acidification and precipitating the product, it is just that the process people are paranoid about the safety and they wanted avoid any chance of hydrazoic acid vapors – literaly a headache-causing problem for the operators who have to filter the stuff on scale

        Under the above described procedures, before granting the MA, the EMA or the competent authorities of the Member States of the EEA make an assessment of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.

In the event of grantee’s termination prior to a vesting date by reason of such grantee’s death or disability, all of such grantee’s RSUs shall immediately become vested as of the date of such termination. In the event of a grantee’s termination for cause prior to settlement, all of such grantee’s RSUs shall immediately be forfeited for no consideration as of the date of such termination. If a grantee’s employment or service is terminated for any other reason, (1) all vesting with respect to such grantee’s RSUs shall cease, (2) all of such grantee’s unvested RSUs shall immediately be forfeited for no consideration as of the date of such termination, and (3) to the extent not already settled, all of such grantee’s vested RSUs shall be settled in accordance with the settlement schedule set forth in the applicable award agreement.

Cephalon, Inc . (NasdaqGS: CEPH ) Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction.

        We are an "emerging growth company," as defined in the JOBS Act, and may remain an emerging growth company for up to five years following our initial public offering. For so long as we remain an

Evgenov, O. V. et al. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov. 5, 755–768 (2006).

Rose, F. et al. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J. 16, 1660–1661 (2002).

Pellieux, C. et al. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J. Mol. Cell. Cardiol. 41, 459–466, 10.1016/j.yjmcc.2006.06.004 (2006).

Aydin, U. et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology 60, 370–377, doi: 10.1177/0003319708321102 (2009).

Haraguchi, T., Ozaki, Y. & Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43 (2009).

糖皮质激素的淋巴细胞效应被认为是其能对急、慢性淋巴细胞白血病和恶性淋巴瘤产生治疗作用的原因。强的松是最常用的药物，因为其抗感染效果是考的松的4到5倍。